NKTR logo Nektar Therapeutics : NKTR

NKTR

Stock Data

$71.04

Change up

$6.65 (10.33%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Nektar Therapeutics is a biopharmaceutical firm based in San Francisco, focusing on creating innovative medicines in immunotherapy. The company is working on treatments for a range of conditions, including systemic lupus erythematosus, ulcerative colitis, atopic dermatitis, psoriasis, non-Hodgkin’s lymphoma, multiple myeloma, and various cancers. With a strong commitment to advancing healthcare, Nektar Therapeutics collaborates with leading pharmaceutical companies worldwide to bring new therapies to patients in need.

All Nektar Therapeutics Articles

60 Articles

1 2 3 4